The shares of Forest Laboratories, Inc. (NYSE:FRX) surged more than 27% to $91.04 per share after the company announced its agreement to sell itself to Actavis Plc (NYSE:ACT) for $89.48 per share or $25...
The shares of Forest Laboratories Inc (NYSE:FRX) and Riverbed Technology Inc (NASDAQ:RVBD) rallied significantly on Wednesday. Reports of acquisition/proposed buyout drove the stocks higher.
Forest Laboratories rose 18% on Aptalis acquisition
The stock price of Forest...